| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |